Enlaye
United States
- Boston, Massachusetts
- 02/10/2024
- Pre-Seed
- $1,700,000
The AI-native Risk Lifecycle Management™ platform for the Built-World, on a mission to help contractors, owners, and developers better identify, assess, compare, and manage risk at all stages of the project lifecycle.
- Industry Software Development
- Website https://www.enlaye.com/
- LinkedIn https://www.linkedin.com/company/enlaye/
Related People
Philippe RivalCo Founder
United States -
Boston, Massachusetts
At Enlaye, we know that to build is to manage risk. That’s why we built the AI-native Risk Management Lifecycle™ platform for the Built-World. Enlaye helps contractors, owners, and developers manage their Risk to build better together.
I am a cofounder of Enlaye and serve as CEO. I oversee the company's strategic direction, team, operations, and growth, focusing on building innovative Built-World Risk AI solutions that drive value for our users.
I am a French-Australian Founder, Entrepreneur, Civil Engineer, and two-time TEDx Speaker. I have 10 years of Built-World experience in Project, Contract, Proposal and Bid Management of Large-Scale Infrastructure and Civil Construction Projects across 5 countries (USA, Canada, UK, France, Australia). I hold an MBA from Harvard Business School and an M.Eng in Civil Engineering from Imperial College London with a year at l’École Nationale des Ponts et Chaussées.
Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)